First Mercantile Trust’s Aerie Pharmaceuticals AERI Stock Holding History

First Mercantile Trust’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$92K	Sell	8,097 -554	-6%	-$8.1K	0.01%	682
2021 Q2	$139K	Sell	8,651 -481	-5%	-$8.25K	0.02%	576
2021 Q1	$163K	Sell	9,132 -394	-4%	-$6.8K	0.02%	516
2020 Q4	$129K	Sell	9,526 -785	-8%	-$9.49K	0.01%	608
2020 Q3	$128K	Sell	10,311 -145	-1%	-$1.77K	0.02%	590
2020 Q2	$154K	Buy	10,456 +2,332	+29%	+$34.5K	0.02%	507
2020 Q1	$110K	Buy	8,124 +1,222	+18%	+$23.2K	0.02%	536
2019 Q4	$167K	Buy	6,902 +2,412	+54%	+$50K	0.02%	525
2019 Q3	$86K	Sell	4,490 -57	-1%	-$1.31K	0.01%	733
2019 Q2	$134K	Buy	+4,547	New	+$175K	0.01%	568
2019 Q1	–	Sell	-4,267	Closed	-$154K	–	938
2018 Q4	$154K	Sell	4,267 -5,055	-54%	-$237K	0.04%	514
2018 Q3	$574K	Buy	9,322 +268	+3%	+$17.2K	0.11%	223
2018 Q2	$612K	Buy	9,054 +1,737	+24%	+$97.2K	0.12%	200
2018 Q1	$397K	Buy	7,317 +530	+8%	+$29.6K	0.08%	299
2017 Q4	$406K	Buy	6,787 +792	+13%	+$48K	0.08%	320
2017 Q3	$291K	Buy	5,995 +474	+9%	+$25.9K	0.05%	452
2017 Q2	$290K	Sell	5,521 -1,510	-21%	-$70.3K	0.05%	458
2017 Q1	$319K	Buy	7,031 +1,620	+30%	+$72.3K	0.05%	463
2016 Q4	$205K	Buy	5,411 +1,140	+27%	+$43.1K	0.03%	579
2016 Q3	$161K	Buy	+4,271	New	+$94.2K	0.02%	645

Other funds holding AERI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

First Mercantile Trust's AERI Position: Q3 2021 in Review

First Mercantile Trust reduced its Aerie Pharmaceuticals (AERI) stake by 6.4% in Q3 2021, selling an estimated $8.1K and leaving 8,097 shares worth $92K. The position accounts for 0.01% of the portfolio, ranked #682.

First Mercantile Trust first reported a position in AERI in Q3 2016 and has held it in 20 quarters since. The position peaked at $612K in Q2 2018. 137 funds tracked by Wall St. Rank hold AERI as of Q3 2021.

First Mercantile Trust held 8,097 shares of Aerie Pharmaceuticals worth $92K as of Q3 2021.
First Mercantile Trust sold 554 Aerie Pharmaceuticals shares in Q3 2021, an estimated $8.1K.
Aerie Pharmaceuticals made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #682 holding.
First Mercantile Trust first reported a position in Aerie Pharmaceuticals in Q3 2016 and has held it in 20 quarters since.
First Mercantile Trust's Aerie Pharmaceuticals position peaked at $612K in Q2 2018.
137 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.